Endocrine dysfunction among adult patients with tuberculosis: An African experience

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 3, 2014, Pages 288-294

  Kibirige, Davis ^a  

^a MKPGMS Uganda Martyrs University   (Uganda)

Author keywords

Africa; endocrine dysfunction; tuberculosis

Indexed keywords

EID: 84995809782     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.131136     Document Type: Review

References (64)

1. Global Tuberculosis Report, 2012 Geneva: World Health Organization; 2012.
2. Kelestimur F. The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function. J Endocrinol Invest 2004;27:380-6.
3. Bulbuloglu E, Ciralik H, Okur E, Ozdemir G, Ezberci F, Cetinkaya A. Tuberculosis of the thyroid gland: Review of the literature. World J Surg 2006;30:149-55.
4. Saluja SS, Ray S, Pal S, Kukeraja M, Srivastava DN, Sahni P, et al. Hepatobiliary and pancreatic tuberculosis: A two decade experience. BMC Surg 2007;7:10.
5. Need AG, Phillips PJ, Chiu F, Prisk H. Hypercalcaemia associated with tuberculosis. Br Med J 1980;280:831.
6. Wise GJ, Marella VK. Genitourinary manifestation of tuberculosis. Urol Clin North Am 2003;30:111-21.
7. Sen T, Joshi SR, Udwadia ZF. Tuberculosis and diabetes mellitus: Merging epidemics. J Assoc Physicians India 2009;57:399-404.
8. Agarwal G, Bhatia E, Pandey R, Jain SK. Clinical profile and prognosis of Addison's disease in India. Natl Med J India 2001;14:23-5.
9. Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf) 2001;54:633-9.
10. Laway BA, Khan I, Shah BA, Choh NA, Bhat MA, Shah ZA. Pattern of adrenal morphology and function in pulmonary tuberculosis: Response to treatment with antitubercular therapy. Clin Endocrinol (Oxf) 2013;79:321-5.
11. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-93.
12. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill Patients. N Engl J Med 2003;348:727-34.
13. Post FA, Soule SG, Wiilcox PA, Levitt NS. The spectrum of endocrine dysfunction in active pulmonary tuberculosis. Clin Endocrinol (Oxf) 1994;40:367-71.
14. Kaplan FJ, Levitt NS, Soule SG. Primary hypoadrenalism assessed by the 1 microg ACTH test in hospitalized patients with active pulmonary tuberculosis. QJM 2000;93:603-9.
15. Ross I, Boulle A, Soule S, Levitt N, Pirie F, Karlsson A, et al. Autoimmunity predominates in a large South African cohort with addison's disease of mainly European descent despite longstanding disease and is associated with HLA DQBFNx010201. Clin Endocrinol 2010;73:291-8.
16. Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. Adrenocortical function in Nigerian patients with pulmonary tuberculosis (PTB). Afr J Med Med Sci 2011;40:33-8.
17. Mugusi F, Swai AB, Turner SJ, Alberti KG, McLarty DG. Hypoadrenalism in Patients with Pulmonary Tuberculosis in Tanzania: An Undiagnosed Complication? Trans R Soc Trop Med Hyg 1999;84:849-51.
18. Soule S. Addison's disease in Africa-a teaching hospital experience. Clin Endocrinol (Oxf) 1999;50:115-20.
19. Francois Venter WD, Panz VR, Feldman C, Joffe BI. Adrenocortical function in hospitalised patients with active pulmonary tuberculosis receiving a rifampicin-based regimen - a pilot study. S Afr Med J 2006;96:62-6.
20. Beadsworth M, van-Oosterhout J, Diver M, Faragher EB, Shenkin A, Mwandumba HC, et al. Hypoadrenalism is not associated with early mortality during tuberculosis treatment in Malawi. Int J Tuberc Lung Dis 2008;12:314-8.
21. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Diabetes is a risk factor for pulmonary tuberculosis: A case-control study from Mwanza, Tanzania. PLoS One 2011;6:e24215.
22. Jeon C, Murray M. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med 2008;5:1091-101.
23. Harriesa A, Billo N, Kapurc A. Links between Diabetes Mellitus and Tuberculosis: Should We Integrate Screening and Care? Trans R Soc Trop Med Hyg 2009;103:1-2.
24. Van-Cromphaut S, Vanhorebeek I, Van-den-Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des 2008;14:1887-99.
25. Marais RM. Diabetes mellitus in black and coloured tuberculosis patients. S Afr Med J 1980;57:483-4.
26. Mugusi F, Swai AB, Alberti KG, McLarty DG. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990;71:271-6.
27. Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990;71:135-8.
28. Baldé NM, Camara A, Camara LM, Diallo MM, Kaké A, Bah-Sow OY. Associated tuberculosis and diabetes in Conakry, Guinea: Prevalence and clinical characteristics. Int J Tuberc Lung Dis 2006;10:1036-40.
29. Kibirige D, Ssekitoleko R, Mutebi E, Worodria W. Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: A cross sectional study. BMC Infect Dis 2013;13:122.
30. Olayinka A, Anthonia O, Yetunde K. Prevalence of diabetes mellitus in persons with tuberculosis in a tertiary health centre in Lagos, Nigeria. Indian J Endocrinol Metab 2013;17:486-9.
31. Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis. Int J Tuberc Lung Dis 2012;16:1680-5.
32. Chung RT, Casson DR, Murray G, Song S, Grinspoon S, Hadigan C. Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy. J Acquir Immune Defic Syndr 2003;34:534-6.
33. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-33.
34. Naing C, Mak J, Ahmed S, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis. World J Gastroenterol 2012;18:1642-51.
35. Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: Pathogenesis and treatment. Nat Rev Endocrinol 2011;7:456-65.
36. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. Diabetes and tuberculosis: The impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007;7:234.
37. Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Trop Med Int Health 2012;17:877-83.
38. Faurholt-Jepsen D, Range N, Praygod G, Kidola J, Faurholt-Jepsen M, Aabye MG, et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: A prospective cohort study from Mwanza, Tanzania. BMC Infect Dis 2012;12:165.
39. Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: A prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health 2013;18:822-9.
40. Harries AD, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health 2010;15:659-63.
41. Ottmani SE, Murray MB, Jeon CY, Baker MA, Kapur A, Lönnroth K, et al. Consultation meeting on tuberculosis and diabetes mellitus: Meeting summary and recommendations. Int J Tuberc Lung Dis 2010;14:1513-7.
42. Standards of Medical Care in Diabetes by the American Diabetes Association, Diabetes Care 2009;32:S13-61.
43. Takasu N, Yamada T, Miura H, Sakamoto S, Korenaga M, Nakajima K, et al. Rifampicin-induced early phase hyperglycemia in humans. Am Rev Respir Dis 1982;125:23-7.
44. Park JY, Kim KA, Park PW, Park CW, Shin JG. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide. Clin Pharmacol Ther 2003;74:334-40.
45. Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 1998;352:306-11.
46. Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987;71:341-4.
47. Okogun G, Johnson J, Otimenbhor J. Total serum calcium and inorganic phosphate levels in tuberculosis patients in Benin City, Nigeria. Sierra Leone J Biomed Res 2010;2:87-90.
48. Dosumu EA, Momoh JA. Hypercalcemia in patients with newly diagnosed tuberculosis in Abuja, Nigeria. Can Respir J 2006;13:83-7.
49. Nansera D, Graziano FM, Friedman DJ, Bobbs MK, Jones AN, Hansen KE. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 2011;15:1522-7.
50. Friis H, Range N, Pedersen M. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr 2008;138:2474-80.
51. Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007;86:1376-83.
52. Banda R, Mhemedi B, Allain TJ. Prevalence of vitamin D deficiency in adult tuberculosis patients at a central hospital in Malawi. Int J Tuberc Lung Dis 2011;15:408-10.
53. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A 2011;108:19013-7.
54. Kibirige D, Mutebi E, Ssekitoleko R, Worodria W, Mayanja-Kizza H. Vitamin D deficiency among adult patients with tuberculosis: A cross sectional study from a national referral hospital in Uganda. BMC Res Notes 2013;6:293.
55. Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008;46:443-6.
56. Conesa-Botella A, Goovaerts O, Massinga-Loembé M, Worodria W, Mazakpwe D, Luzinda K, et al. Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis 2012;16:1517-21.
57. Holick MF. Vitamin D Deficiency. N Engl J Med 2007;357.
58. Kelechi E, Aileen C. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int J Epidemiol 2008;37:113-9.
59. Liu P, Stenger S, Tang D. Cutting edge: Vitamin D mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179:2060-3.
60. Hmama Z, Sendide K, Talal A, Garcia R, Dobos K, Reiner NE. Quantitative analysis of phagolysosome fusion in intact cells: Inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha, 25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci 2004;117:2131-40.
61. Mebis L, Van-den-Berghe G. Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab 2011;25:745-57.
62. Borggreve HF, Kiers A, de-Heide LJ. A somali man with a painful thyroid mass: Thyroid tuberculosis. Ned Tijdschr Geneeskd 2005;149:1954-7.
63. Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: Who to treat and how. Drugs 2012;72:17-33.
64. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008;159:507-14.